SCHEMBL97737

SCHEMBL97737

CC[C@H](O)CC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL322745 1.00
SCHEMBL1505898 1.00
SCHEMBL13286127 0.89 TSHR (0.39)
SCHEMBL14337002 0.89 TSHR (0.39)
SCHEMBL28243 0.87 TSHR (0.50)
SCHEMBL15892735 0.85 KDM4E (0.41)
SCHEMBL11607945 0.84 MGAM (0.41)
SCHEMBL21551859 0.83 L3MBTL1 (0.49)
SCHEMBL21551893 0.83 L3MBTL1 (0.49)
SCHEMBL21551920 0.83 L3MBTL1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612407-B2 Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist BEONE MEDICINES I GMBH (CH) 2026-04-28 US disclosed
CN-113423708-B Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR7 agonists 百济神州有限公司 2025-04-22 CN disclosed
EP-3921319-B1 IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEIGENE LTD (KY) 2024-03-06 EP disclosed
US-20230167117-A1 IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEONE MEDICINES I GMBH (CH) 2023-06-01 US disclosed
US-9399645-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-07-26 US disclosed
US-9399645-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-07-26 US disclosed
US-9250238-B2 Pathogen detection PURDUE RESEARCH FOUNDATION (US) 2016-02-02 US disclosed
US-9250238-B2 Pathogen detection PURDUE RESEARCH FOUNDATION (US) 2016-02-02 US disclosed
CN-102947310-B Fused pyridine compounds as dual modulators of the 5-HT2A and D3 receptors HOFFMAN-LA ROCHE LTD. (CH) 2015-11-25 CN disclosed
CN-102958936-B The pyridine compounds condensed HOFFMAN-LA ROCHE LTD. (CH) 2015-10-21 CN disclosed
WO-2011037793-A1 SUBSTITUTED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES MERCK SHARP & DOHME CORP. (US) 2011-03-31 WO disclosed
US-20090311762-A1 OXIDOREDUCTASES FOR THE STEREOSELECTIVE REDUCTION OF KETO COMPOUNDS IEP GMBH (DE) 2009-12-17 US disclosed
EP-1907556-A1 OXIDOREDUCTASES FOR THE STEREOSELECTIVE REDUCTION OF KETO COMPOUNDS IEP GmbH (DE) 2008-04-09 EP disclosed
WO-2007012428-A1 OXIDOREDUCTASES FOR THE STEREOSELECTIVE REDUCTION OF KETO COMPOUNDS IEP GMBH (DE) 2007-02-01 WO disclosed
EP-1595887-B1 Chiral C2-symmetric biphenyls, preparation thereof as well as metal complexes containing these ligands and the use as catalysts in chirogene synthesis CONSORTIUM ELEKTROCHEM IND (DE) 2006-10-25 EP disclosed
EP-1595887-A1 Chiral C2-symmetric biphenyls, preparation thereof as well as metal complexes containing these ligands and the use as catalysts in chirogene synthesis Consortium für elektrochemische Industrie GmbH (DE) 2005-11-16 EP disclosed
US-6384228-B2 EPIBATIDINE; ANALGESICS; ANIMAL EXTRACTS NIHON MEDI-PHYSICS CO., LTD. (JP) 2002-05-07 US disclosed
US-20020010339-A1 METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF NIHON MEDI-PHYSICS CO., LTD. (JP) 2002-01-24 US disclosed
US-5128252-A Resolution of optically active esters, transesterification, lipase CHISSO CORPORATION (JP) 1992-07-07 US disclosed
EP-0384189-A2 Optically active compound and a process for the production thereof CHISSO CORPORATION (JP) 1990-08-29 EP disclosed